We detected the expression of CD44 in tumor cells of the metastases by multiple immunofluorescences and analyzed the correlation between EGR1 and CD44 in the tumor components of the metastatic tumor (mesothelial cells were positioned by HBME1). The gene discussed is CD44; the disease is neoplasm.